Protagenic Therapeutics, Inc. (PTIX)
1.026
-0.03
(-3.22%)
USD |
OTCM |
Sep 08, 16:00
Protagenic Therapeutics Debt to Equity Ratio : 0.00 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | -1.670 |
| September 30, 2025 | -0.8504 |
| June 30, 2025 | -1.010 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 0.00 |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.1011 |
| June 30, 2023 | 0.0728 |
| March 31, 2023 | 0.0575 |
| December 31, 2022 | 0.0498 |
| September 30, 2022 | 0.0432 |
| June 30, 2022 | 0.0355 |
| March 31, 2022 | 0.0338 |
| December 31, 2021 | 0.032 |
| September 30, 2021 | 0.0542 |
| June 30, 2021 | 0.0613 |
| March 31, 2021 | -0.7706 |
| December 31, 2020 | -1.195 |
| September 30, 2020 | -1.284 |
| June 30, 2020 | -1.52 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.9345 |
| December 31, 2019 | -0.4404 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.0244 |
| June 30, 2015 | -1.036 |
| March 31, 2015 | -1.078 |
| December 31, 2014 | -1.560 |
| September 30, 2011 | -0.7114 |
| June 30, 2011 | -2.874 |
| March 31, 2011 | 0.00 |
| December 31, 2010 | 0.00 |
| September 30, 2010 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 2.956 |
| Oncolytics Biotech, Inc. | -0.0726 |
| Sangamo Therapeutics, Inc. | -1.020 |
| Sarepta Therapeutics, Inc. | 0.6845 |
| Anixa Biosciences, Inc. | 0.0127 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 2.796M |
| Total Liabilities (Quarterly) | 1.073M |
| Shareholders Equity (Quarterly) | 1.723M |
| Current Ratio | 0.6619 |